AlphaYou
Overview
Smart-money signal on IQV this 14d.
Key stats
Sep 5- Open
- $268.48
- 52-wk high
- $271.80
- High
- $271.80
- 52-wk low
- $154.50
- Low
- $262.60
- Prev close
- $271.62
- Mkt cap
- $43.80B
- P/E
- 33.1x
- Volume
- 1.20M
- Fwd P/E
- 17.8x
- Beta
- 1.19
- P/S
- 2.6x
- P/B
- 6.9x
- Profit margin
- +8.1%
- Op margin
- +13.0%
- ROE
- +22.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 1.1% above what analysts expected.
Earnings per share
$2.72 expected
Revenue
No comparable estimate
Company adjusted EPS
From the company's release
The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.
Full-year 2026 guidance
$17.27B to $17.48B
No comparable estimate
Reports Oct 27, 2026, in 52 days
EPS expected
$3.22 to $3.54
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.10B | $4.36B | $4.15B | $4.37B |
| Cost of what it sold | $2.73B | $4.07B | $2.80B | $2.93B |
| Gross profit | $1.37B | $292.0M | $1.35B | $1.44B |
| What it spent | ||||
| Sales and admin | $514.0M | $468.0M | $502.0M | $574.0M |
| Other operating costs | $306.0M | -$908.0M | $339.0M | $355.0M |
| Total operating expenses | $820.0M | -$440.0M | $841.0M | $929.0M |
| What was left | ||||
| Operating profit | $553.0M | $732.0M | $514.0M | $506.0M |
| Interest on debt | $189.0M | $193.0M | $192.0M | $197.0M |
| Profit before tax | $408.0M | $572.0M | $328.0M | $301.0M |
| Tax | $76.0M | $58.0M | $59.0M | $60.0M |
| Net profit | $331.0M | $514.0M | $274.0M | $256.0M |
| EBITDA | $883.0M | $1.05B | $808.0M | $790.0M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
IQVIA stock hits 52-week high at 265.29 USD By Investing.com
BullishSep 3IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors
BearishSep 1HSBC Adjusts Price Target on IQVIA Holdings to $300 From $280, Maintains Buy Rating
BullishSep 1(IQV) Movement Within Algorithmic Entry Frameworks
NeutralSep 120 Companies in Clinical Trial Technology and Services Market
BullishAug 31Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial
Leans bullishAug 30IQVIA Holdings Inc. (IQV) Peer Comparison – Compare with Others
NeutralAug 30IQVIA's AI tool cut diabetes screening work by 99.5% and won an award
BullishAug 28
Macro
32 macro signals shaping IQV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results